Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Tag: Mylan

Profit Over Patients: Indiana Wins Settlement from Viatris and Pfizer in...

The End of an Era: What the EpiPen Patent Expiration Means...

Mylan, After Agreeing to Pay $73.5M to Settle Antitrust Claims by...

New NY State Law Mandates Auto-Injector Coverage and Limits Out-of-Pocket Expenses

Epinephrine Auto-Injector Manufacturer Sues State Over Affordability Program

Court Approves $50 Million Pfizer Settlement for EpiPen Price-Fixing Scheme

Editorial: Exploiting Food Allergies for Profit

Pharma Company Pushes Back on State’s Efforts to Make Epinephrine Affordable

Pfizer Will Pay $50M to Settle EpiPen Antitrust Claims

Why the FDA Changed Course at the Last Minute to Deny...

Follow Us

Your School On Our Map

Put Your School on the Map